Emergent BioSolutions Inc. (EBS) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2010: $369.46M2011: $414.25M2012: $441.36M2013: $489.62M2014: $553.20M2016: $596.20M2017: $912.30M2018: $1.01B2019: $1.09B2020: $1.45B2021: $1.61B2022: $1.39B2023: $649.30M2024: $482.80M2025: $522.60M$522.60M
2010Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$522.60M+8.2%
2024$482.80M-25.6%
2023$649.30M-53.2%
2022$1.39B-13.9%
2021$1.61B+11.1%
2020$1.45B+33.0%
2019$1.09B+8.0%
2018$1.01B+10.8%
2017$912.30M+53.0%
2016$596.20M
2014$553.20M+13.0%
2013$489.62M+10.9%
2012$441.36M+6.5%
2011$414.25M+12.1%
2010$369.46M